Central Asia
Showing 1 - 25 of 8,364
Opioid Use Disorder Trial in Worldwide (NIATx)
Not yet recruiting
- Opioid Use Disorder
- NIATx
-
New Haven, Connecticut
- +3 more
Oct 10, 2022
HIV Testing, Intention Trial in Almaty (AEGIDA intervention arm, AEGIDA control arm)
Active, not recruiting
- HIV Testing
- Intention
- AEGIDA intervention arm
- AEGIDA control arm
-
Almaty, KazakhstanGlobal Health Research Center of Central Asia
Nov 17, 2023
HIV, Substance-Related Disorders Trial in New York, Almaty (Peer Unity)
Completed
- HIV
- Substance-Related Disorders
- Peer Unity
-
New York, New York
- +1 more
May 23, 2022
Human Immunodeficiency Virus, Substance Abuse, Intravenous Trial in New York, Almaty (BRIDGE)
Completed
- Human Immunodeficiency Virus
- Substance Abuse, Intravenous
- BRIDGE
-
New York, New York
- +1 more
May 26, 2022
Stigma, Social, HIV Testing Trial in Almaty (Digital Crowdsourced Intervention to Reduce HIV Stigma among Adolescents and Young
Not yet recruiting
- Stigma, Social
- HIV Testing
- Digital Crowdsourced Intervention to Reduce HIV Stigma among Adolescents and Young Adults
-
Almaty, KazakhstanColumbia University Global Health Research Center of Central Asi
Oct 5, 2022
HIV, Substance Use Disorders Trial in Almaty (SMART Couples 2, Standard of Care)
Recruiting
- HIV Infections
- Substance Use Disorders
- SMART Couples 2
- Standard of Care
-
Almaty, KazakhstanColumbia University Global Health Research Center of Central Asi
Mar 7, 2022
Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis Trial in Worldwide (Early Intervention)
Recruiting
- Cardiovascular Diseases
- +3 more
- Early Intervention
-
Wollongong, New South Wales, Australia
- +15 more
Nov 6, 2022
Fabulous® Thoracic Aortic Stent System for Stanford B Aortic
Not yet recruiting
- Aortic Dissection
- Fabulous Thoracic Aortic Stent System
-
Harbin, Heilongjiang, China
- +6 more
Aug 1, 2023
COVID-19, SARS CoV 2 Infection Trial in Australia (ChulaCov19 BNA159 vaccine (50 mcg), Pfizer/BNT vaccine (30 mcg))
Not yet recruiting
- COVID-19, SARS CoV 2 Infection
- ChulaCov19 BNA159 vaccine (50 mcg)
- Pfizer/BNT vaccine (30 mcg)
-
Bruce, Australian Capital Territory, Australia
- +4 more
Nov 15, 2022
Trochanteric Fracture of Femur Trial in Japan (Open Reduction and Internal Fixation, ZNN CM Asia, Anterior Support Screw)
Completed
- Trochanteric Fracture of Femur
- Open Reduction and Internal Fixation
- +2 more
-
Kure, Hiroshima, Japan
- +11 more
Sep 8, 2020
ST-Segment Elevation Myocardial Infarction Participants
Completed
- Coronary Artery Disease
- ST-segment Elevation Myocardial Infarction
-
Kaifeng, Contact:, China
- +35 more
Jan 6, 2022
Heart Failure Trial in China (NoYA™ Radiofrequency Interatrial Shunt System)
Recruiting
- Heart Failure
- NoYA™ Radiofrequency Interatrial Shunt System
-
Bengbu, Anhui, China
- +30 more
May 10, 2022
Asia Glaucoma Registry
Active, not recruiting
- POAG
-
Hong Kong, Hong KongLeung Kai Shun
Mar 3, 2022
ST-segment Elevation Myocardial Infarction (STEMI) Trial in China (Thrombus aspiration)
Recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- Thrombus aspiration
-
Fuzhou, Fujian, China
- +49 more
Mar 2, 2021
Left Atrial Appendage Occlusion With The Amplatzer Amulet
Recruiting
- Atrial Fibrillation
- Amplatzer Amulet Left Atrial Appendage Occlusion Device
-
Kuching, Sarawak, MalaysiaSarawak Heart Centre
Jan 26, 2023
Acute Pulmonary Embolism Trial in China (Recombinant Human Prourokinase, Alteplase)
Completed
- Acute Pulmonary Embolism
- Recombinant Human Prourokinase
- Alteplase
-
Beijing, Beijing, China
- +17 more
Mar 16, 2021
Rheumatoid Arthritis Trial (probiotic therapy)
Not yet recruiting
- Rheumatoid Arthritis
- probiotic therapy
- (no location specified)
Mar 8, 2023
Gestational Diabetes in Central Asia: Prevalence and Management
Completed
- Gestational Diabetes Mellitus
- Observation
-
Munich, GermanyMed. Dept. 2, University Munich
Feb 26, 2019
Hb Scope: A Multi-Center Validation Trial
Not yet recruiting
- Hemoglobin
- Hemodialysis
- Hb Scope APP
- (no location specified)
May 1, 2023
Retinal Vein Occlusion Trial in France
Active, not recruiting
- Retinal Vein Occlusion
-
Créteil, France
- +8 more
Aug 17, 2022
Rural South and Southeast Asia Household Health Survey
Recruiting
- Noncommunicable Disease
- +3 more
-
Dhaka, Bangladesh
- +3 more
Jan 5, 2023
NSCLC Trial in Australia, China, Korea, Republic of (AZD9291)
Active, not recruiting
- Non-Small Cell Lung Cancer
-
Kogarah, Australia
- +29 more
Oct 20, 2022
Antibiotic Resistance, Respiratory Tract Infections, Pediatric Infectious Disease Trial (CRP POCT (C-reactive protein point of
Not yet recruiting
- Antibiotic Resistance
- +3 more
- CRP POCT (C-reactive protein point of care test)
- (no location specified)
Apr 25, 2022